GoodRx Holdings (GDRX) Revenue (2019 - 2026)

GoodRx Holdings has disclosed Revenue across 8 years of filings, most recently posting $200.4 million for Q2 2026.

• In Q2 2026, Revenue fell 1.31% year-over-year to $200.4 million; the TTM figure through Jun 2026 stood at $785.2 million (down 1.83% YoY), while the FY2025 annual figure was $796.9 million, up 0.57% from the prior year.
• Revenue came in at $200.4 million for Q2 2026 at GoodRx Holdings, up from $194.0 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $203.3 million in Q1 2022 to a low of $180.0 million in Q3 2023.
• Average Revenue over 5 years is $194.5 million, with a median of $195.6 million recorded in 2024.
• The largest YoY upside for Revenue was 26.74% in 2022 against a maximum downside of 13.67% in 2022.
• Over 5 years, Revenue stood at $184.1 million in 2022, then advanced by 6.81% to $196.6 million in 2023, then gained by 0.99% to $198.6 million in 2024, then declined by 1.91% to $194.8 million in 2025, then climbed by 2.89% to $200.4 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $200.4 million in Q2 2026, $194.0 million in Q1 2026, and $194.8 million in Q4 2025.